文献速递真菌感染医院感染防控

感染科会诊对念珠菌血流感染患者死亡率和治疗的影响:一项回顾性队列研究

Effect of infectious disease consultation on mortality and treatment of patients with candida bloodstream infections: a retrospective, cohort study.
PubMed 文献 · Lancet Infect Dis · 2019-09-24

这项回顾性单中心队列研究分析了1691例念珠菌血流感染患者,其中776例接受了感染科会诊。会诊组抗真菌治疗时间更长,中心静脉拔除、超声心动图和眼科检查更频繁,未治疗比例更低。

要点

  • 感染科会诊与念珠菌血流感染患者90天死亡率降低独立相关。
  • 会诊组更多接受中心静脉拔除、超声心动图和眼科检查等循证干预。
  • 会诊组抗真菌治疗中位时间更长,未治疗比例更低。

核心结论

  • 感染科会诊与念珠菌血流感染患者较低的死亡率相关,可能归因于更多非药物循证干预和更少的未治疗。

研究设计与样本

  • 回顾性单中心队列研究,纳入2002年至2015年Barnes-Jewish医院1691例成人念珠菌血流感染患者,比较有无感染科会诊者的90天全因死亡率。

临床怎么用

  • 念珠菌血流感染患者应考虑常规进行感染科会诊,以优化循证干预和抗真菌治疗。

局限性

  • 回顾性单中心设计可能引入选择偏倚和未测量混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Candida bloodstream infection is associated with high mortality. Infectious disease consultation improves outcomes in several infections, including Staphylococcus aureus and cryptococcosis, as well as multidrug-resistant organisms. We aimed to examine the association between infectious disease consultation and differences in management with mortality in candida bloodstream infections. METHODS: In this retrospective, single-centre cohort study, we reviewed the medical charts of all patients admitted to Barnes-Jewish Hospital (St Louis, MO, USA), a tertiary referral centre, aged 18 years or older with candida bloodstream infection from 2002 to 2015. We collected data for demographics, comorbidities, predisposing factors, all-cause mortality, antifungal use, central-line removal, and ophthalmological and echocardiographic evaluation to assess 90-day all-cause mortality between individuals with and without an infectious disease consultation. For the survival analysis we used Cox proportional hazards model with inverse weighting by propensity score to assess the effects of infectious disease consultation on mortality and differences in management. FINDINGS: Between Jan 1, 2002, and Dec 31, 2015, of 1794 patients assessed for eligibility, we analysed 1691 patients with candida bloodstream infection; 776 (45·9%) who had an infectious disease consultation and 915 (54·1%) who did not have an infectious disease consultation. All 1691 patients were included in the analysis. None were missing data. Most underlying comorbidities were evenly distributed between groups. 90-day mortality was lower in the infectious disease consultation group than in patients who did not receive an infectious disease consultation (29% [222/776] vs 51% [468/915]; p<0·0001). In the model with inverse weighting by the propensity score, infectious disease consultation was associated with a hazard ratio of 0·81 (95% CI 0·73-0·91; p<0·0001) for mortality. In the consultation group, median duration of antifungal therapy was longer (18 [IQR 14-35] vs 14 [6-20] days; p<0·0001) and central-line removal (587 [76%] of 776 vs 538 [59%] of 915; p<0·0001), echocardiography use (442 [57%] of 776 vs 305 [33%] of 915; p<0·0001), and ophthalmological examination (412 [53%] of 776 vs 160 [17%] of 915; p<0·0001) were more frequently done. Fewer patients in the infectious disease consultation group were not treated (13 [2%] of 776 vs 128 [14%] of 915; p<0·0001). INTERPRETATION: Patients with candida bloodstream infection receiving an infectious disease consultation have lower mortality. This finding might be attributable to these individuals receiving a higher number of non-pharmacological, evidence-based interventions and lower amounts of non-treatment. These data suggest that an infectious disease consultation should be an integral part of clinical care of patients with candida bloodstream infection. FUNDING: Astellas Global Development Pharma, Washington University Institute of Clinical and Translational Sciences, and the Agency for Healthcare Research and Quality.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Mejia-Chew C, O'Halloran JA, Olsen MA, et al. Effect of infectious disease consultation on mortality and treatment of patients with candida bloodstream infections: a retrospective, cohort study. Lancet Infect Dis. 2019. PMID: 31562024. doi:10.1016/S1473-3099(19)30405-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。